Using location services to autonomously drive flying mobile sinks in Wireless Sensor Networks

International audienceThe use of mobility in a Wireless Sensor Network has already been indicated as a feature whose exploitation would increase the performances and the ease of mantainance in these environments. Expecially in a event-based WSN, where is necessary a prompt response in terms of data processing and o oading, a set of mobile ying sinks could be a good option for the role of autonomous data collectors. For those reasons in this paper we propose a distributed algorithm to independently and autonomously drive a mobile sink through the nodes of a WSN and we show its preferability over more classical routing approaches expecially in the presence of a localized generation of large amount of information. Our result shows that, in the case of fairly complete coverage of the area where the nodes lie, it is possible to promptly notify a mobile sink about the presence of data to o oad, drive it to the interested area and achieve interesting performances

A new mHealth communication framework for use in wearable WBANs and mobile technologies

Driven by the development of biomedical sensors and the availability of high mobile bandwidth, mobile health (mHealth) systems are now offering a wider range of new services. This revolution makes the idea of in-home health monitoring practical and provides the opportunity for assessment in “real-world” environments producing more ecologically valid data. In the field of insomnia diagnosis, for example, it is now possible to offer patients wearable sleep monitoring systems which can be used in the comfort of their homes over long periods of time. The recorded data collected from body sensors can be sent to a remote clinical back-end system for analysis and assessment. Most of the research on sleep reported in the literature mainly looks into how to automate the analysis of the sleep data and does not address the problem of the efficient encoding and secure transmissions of the collected health data. This article reviews the key enabling communication technologies and research challenges for the design of efficient mHealth systems. An end-to-end mHealth system architecture enabling the remote assessment and monitoring of patient’s sleep disorders is then proposed and described as a case study. Finally, various mHealth data serialization formats and machine-to-machine (M2M) communication protocols are evaluated and compared under realistic operating conditions

Perinatal lethal type II osteogenesis imperfecta: a case report

We report a new case of osteogenesis imperfecta (OI) type II which is a perinatal lethal form. First trimester ultrasound didn't identified abnormalities. Second trimester ultrasound showed incurved limbs, narrow chest, with hypomineralization and multiple fractures of ribs and long bones. Parents refused pregnancy termination; they felt that the diagnosis was late. At birth, the newborn presented immediate respiratory distress. Postnatal examination and bone radiography confirmed the diagnosis of OI type IIA. Death occurred on day 25 of life related to respiratory failure

Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases

STUDY DESIGN: Retrospective, observational study in five consecutive cases. OBJECTIVES: The management of heterotopic ossification (HO), a frequent complication after spinal cord injury (SCI) and after orthopaedic surgery, is a therapeutic challenge with high recurrence rates of over 50%. Conflicting data were reported for Etidronate. The use of the more potent new generation of amino-bisphosphonates has been put forward in different inflammatory, dysmorphogenic bone disease. In order to try and halt the underlying dysfunctional bone metabolism we have studied the action of pamidronate in five consecutive high-risk patients with established HO of different etiology undergoing surgical removal. SETTING: University Hospital of Basel, Switzerland, Division of Endocrinology, Diabetology and Clinical Nutrition and the Department of Orthopedic Surgery. METHODS: In all five patients, ranging from 47 to 68 years of age, we used continuous pamidronate infusions perioperatively at a dosage of 120 mg in the first 12 h and subsequent reduction to 75-60-30-15 mg/12 h over a period of 10-14 days. RESULTS: None of these patients showed clinical, radiographical and laboratory signs of HO recurrence or new forming HO in the follow-up 5-54 month after surgery. Potential side effects of high-dose bisphosphonate therapy such as osteoporosis and osteomalacia were not reported in any case. CONCLUSION: We postulate that pamidronate might have pronounced beneficial effects in high-risk patients with established HO undergoing excision surgery. Since the therapeutic window of amino-bisphosphonates has not yet been defined and the minimal necessary doses for preventing new HO are unknown, further studies are encouraged to confirm our findings and to identify the necessary dosage and duration of treatment and to pinpoint, which patients will benefit most from this treatment